Jeevan Scientific Technology's board approved the financial results for the quarter.

Standalone revenue was ₹8.22 Cr with a net loss of ₹2.16 Cr.

Consolidated revenue stood at ₹8.80 Cr, showing a net loss of ₹3.22 Cr.

The board re-appointed Mr. Krishna Kishore Kuchipudi as MD for three years and appointed Mr. Gollapinni Mallikarjuna as a new independent director, both subject to shareholder approval.

Directors Mr. Diwakar Atluri and Mr. Jeevan Krishna Kuchipudi will also be re-appointed by rotation.

Mr. Thammareddy Ravi resigned.

The company also approved granting 3 lakh stock options to employees and a subsidiary, following the Nomination and Remuneration Committee's proposal, and announced its upcoming Annual General Meeting.